Lele Jing
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
- Nephrology top 10%
- Parathyroid Disorders and Treatments
Papers in
-
- Gut microbiota and health 2
-
- Advanced Glycation End Products research 5
- Co-authors
- Huilin Hu (6 shared papers)Zhen Sun (12 shared papers)Zhongqun Wang (12 shared papers)Chen Shao (11 shared papers)Lili Zhang (10 shared papers)Jinchuan Yan (9 shared papers)Lihua Li (8 shared papers)Zhengyang Bao (11 shared papers)
- Journals
- Journal of Cardiovascular Pharmacology (3 papers)Frontiers in Cardiovascular Medicine (2 papers)Journal of Immunology Research (1 paper)Frontiers in Medicine (1 paper)Clinical Cardiology (1 paper)
- Partner nations
- China
In The Last Decade
Lele Jing
19 papers receiving 430 citations
Peers
Comparison fields: 5 of 59
- Clinical Biochemistry 46
- Nephrology 40
- Cancer Research 64
- Immunology 80
- Endocrinology, Diabetes and Metabolism 51
Countries citing papers authored by Lele Jing
This map shows the geographic impact of Lele Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lele Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lele Jing more than expected).
Fields of papers citing papers by Lele Jing
This network shows the impact of papers produced by Lele Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lele Jing. The network helps show where Lele Jing may publish in the future.
Co-authors
The 25 scholars most cited alongside Lele Jing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 84 | |
| 2 | 2020 | 50 | |
| 3 | 2022 | 44 | |
| 4 | 2018 | 39 | |
| 5 | 2020 | 30 | |
| 6 | 2019 | 27 | |
| 7 | 2020 | 24 | |
| 8 | 2017 | 23 | |
| 9 | 2019 | 20 | |
| 10 | 2019 | 16 | |
| 11 | 2020 | 14 | |
| 12 | 2024 | 11 | |
| 13 | 2020 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2022 | 10 | |
| 16 | 2019 | 10 | |
| 17 | 2020 | 5 | |
| 18 | 2017 | 2 | |
| 19 | 2025 | 1 |
About Lele Jing
Lele Jing is a scholar working on Molecular Biology, Clinical Biochemistry, Immunology, Nephrology and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 431 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (5 papers), Galectins and Cancer Biology (2 papers), Gut microbiota and health (2 papers), Parathyroid Disorders and Treatments (2 papers), Diet and metabolism studies (2 papers), Nitric Oxide and Endothelin Effects (1 paper), Ferroptosis and cancer prognosis (1 paper) and Biomarkers in Disease Mechanisms (1 paper). The work is most often cited by research in Clinical Biochemistry (46 citations), Nephrology (40 citations), Cancer Research (64 citations), Immunology (80 citations) and Endocrinology, Diabetes and Metabolism (51 citations). Lele Jing has collaborated with scholars based in China. Frequent co-authors include Huilin Hu, Zhen Sun, Zhongqun Wang, Chen Shao, Lili Zhang, Jinchuan Yan, Lihua Li, Zhengyang Bao, Changlin Zhai and Liang Shen. Their work appears in journals such as Journal of Cardiovascular Pharmacology, Frontiers in Cardiovascular Medicine, Journal of Immunology Research, Frontiers in Medicine and Clinical Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.